Harris Todd has filed 26 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 1463 shares of Tyra Biosciences, Inc. ($TYRA) on March 13, 2026.
Activity breakdown: 0 open-market purchases and 20 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Common Stock | 1463 | $9.13 | 1,358,631.0000 | 59,670,757 | 0.11% | 0.00% |
| Aug. 7, 2025 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Stock Option (Right to Buy) | 570000 | $0.00 | 570,000.0000 | 57,217,746 | 9999.99% | 1.00% |
| March 14, 2025 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Common Stock | 1241 | $9.78 | 1,357,168.0000 | 57,217,746 | 0.09% | 0.00% |
| Oct. 21, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 5896 | $27.32 | 1,369,115.0000 | 58,874,497 | 0.43% | 0.01% |
| Oct. 21, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 13188 | $28.16 | 1,355,927.0000 | 58,874,497 | 0.96% | 0.02% |
| Oct. 18, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 43636 | $27.01 | 1,375,011.0000 | 58,874,497 | 3.08% | 0.07% |
| Oct. 16, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 4900 | $25.22 | 1,462,438.0000 | 58,874,497 | 0.33% | 0.01% |
| Oct. 16, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 24475 | $26.23 | 1,437,963.0000 | 58,874,497 | 1.67% | 0.04% |
| Oct. 16, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 3922 | $26.98 | 1,434,041.0000 | 58,874,497 | 0.27% | 0.01% |
| Oct. 17, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 15194 | $25.84 | 1,418,847.0000 | 58,874,497 | 1.06% | 0.03% |
| Oct. 17, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 200 | $26.37 | 1,418,647.0000 | 58,874,497 | 0.01% | 0.00% |
| Oct. 15, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 10035 | $24.31 | 1,467,338.0000 | 58,874,497 | 0.68% | 0.02% |
| Sept. 30, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 500 | $24.00 | 1,477,373.0000 | 42,704,876 | 0.03% | 0.00% |
| Sept. 24, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 1055 | $24.02 | 1,478,473.0000 | 42,704,876 | 0.07% | 0.00% |
| Sept. 25, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 600 | $24.01 | 1,477,873.0000 | 42,704,876 | 0.04% | 0.00% |
| Sept. 23, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 10092 | $24.13 | 1,479,528.0000 | 42,704,876 | 0.68% | 0.02% |
| Sept. 19, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 5671 | $24.30 | 1,496,756.0000 | 42,704,876 | 0.38% | 0.01% |
| Sept. 19, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 27 | $25.10 | 1,496,729.0000 | 42,704,876 | 0.00% | 0.00% |
| Sept. 20, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 7109 | $24.19 | 1,489,620.0000 | 42,704,876 | 0.47% | 0.02% |
| Sept. 18, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 3500 | $24.00 | 1,502,427.0000 | 42,704,876 | 0.23% | 0.01% |
| Sept. 13, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Common Stock | 1350 | $6.58 | 1,505,927.0000 | 42,704,876 | 0.09% | 0.00% |
| Aug. 14, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Stock Option (Right to Buy) | 390000 | $0.00 | 390,000.0000 | 42,704,876 | 9999.99% | 0.91% |
| March 15, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | A | Common Stock | 1880 | $6.58 | 1,504,577.0000 | 42,704,876 | 0.13% | 0.00% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 78996 | $16.45 | 1,523,701.0000 | 42,704,876 | 4.93% | 0.18% |
| Feb. 2, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 7187 | $17.04 | 1,516,514.0000 | 42,704,876 | 0.47% | 0.02% |
| Feb. 5, 2024 | Tyra Biosciences, Inc. | $TYRA | Harris Todd | President and CEO | S | Common Stock | 13817 | $16.97 | 1,502,697.0000 | 42,704,876 | 0.91% | 0.03% |